v3.25.4
Stock-Based Compensation (Tables)
 6 Months Ended
Dec. 31, 2025
Stock-Based Compensation [Abstract]  
Schedule of Restricted Stock Awards Each vesting installment is subject to the recipient’s continued service with the Company through the applicable vesting date.
   December 31, 2025 
   Three Months Ended   Six Months Ended 
   Number of
Shares		   Weighted
Average
Grant Date
Fair Value
per Price		   Number of
Shares		   Weighted
Average
Grant Date
Fair Value
per Price		 
Beginning balance   73,500   $20.46    
-
   $
-
 
Granted   87,458    15.89    163,861    17.96 
Vested   (4,666)   16.11    (7,569)   16.50 
Canceled   
-
    
-
    
-
    
-
 
Ending balance   156,292   $18.03    156,292   $18.03 
Schedule of Estimates Fair Value of Each Option Award The Company used the following assumptions to estimate the fair value of stock options for the period presented:
   Six Months Ended
December 31,		 
   2025   2024 
Weighted-average fair value  $15.67   $1.89 
Expected volatility   101.4% - 119.2%   113.9% - 122.4%
Expected term   5.0 years - 6.1 years    1.0 years - 5.3 years 
Dividend yield   0.00%   0.00%
Risk-free interest rate   3.69% - 4.07%   3.87% - 4.31%
Schedule of Stock Option Activity

The following is a schedule summarizing stock option activities for the periods presented ($ in thousands, except per share data):

   Number of
Options		   Weighted
Average
Exercise Price		   Aggregate
Intrinsic
Value (1)		 
Outstanding at October 1, 2025   1,704,277   $6.74   $16,678 
Granted   77,000    15.65      
Exercised   (24,749)   2.31      
Canceled   (32,459)   5.65      
Outstanding at December 31, 2025   1,724,069   $7.22   $17,688 
Exercisable at December 31, 2025   1,065,014   $4.50   $13,507 
   Number of
Options		   Weighted
Average
Exercise Price		   Aggregate
Intrinsic
Value (1)		 
Outstanding at October 1, 2024   1,056,487   $2.42   $795 
Granted   54,000    3.12      
Exercised   (155,666)   2.11      
Canceled   
-
    
-
      
Outstanding at December 31, 2024   954,821   $2.51   $4,908 
Exercisable at December 31, 2024   665,348   $2.44   $3,470 

 

(1) Represents the excess of the fair value on the last day of the period (which was $17.17 and $7.65 as of December 31, 2025 and 2024, respectively) over the exercise price, multiplied by the number of options.
   Number of
Options		   Weighted
Average
Exercise Price		   Aggregate
Intrinsic
Value (1)		 
Outstanding at July 1, 2025   1,570,675   $5.33   $17,410 
Granted   234,906    18.74      
Exercised   (46,936)   2.51      
Canceled   (34,576)   5.79      
Outstanding at December 31, 2025   1,724,069   $7.22   $17,688 
Exercisable at December 31, 2025   1,065,014   $4.50   $13,507 

 

   Number of
Options		   Weighted
Average
Exercise Price		   Aggregate
Intrinsic
Value (1)		 
Outstanding at July 1, 2024   1,068,446   $2.41   $1,258 
Granted   66,000    3.12      
Exercised   (155,666)   2.11      
Canceled   (23,959)   2.39      
Outstanding at December 31, 2024   954,821   $2.51   $4,908 
Exercisable at December 31, 2024   665,348   $2.44   $3,470 

 

(1) Represents the excess of the fair value on the last day of the period (which was $17.17 and $7.65 as of December 31, 2025 and 2024, respectively) over the exercise price, multiplied by the number of options.